Salta al contenuto principale
Passa alla visualizzazione normale.

STEFANIA GRIMAUDO

Fibronectin type III domain-containing protein 5 rs3480 A>G polymorphism, irisin, and liver fibrosis in patients with Nonalcoholic fatty liver disease

  • Autori: Petta, S.; Valenti, L.; Svegliati Baroni, G.; Ruscica, M.; Pipitone, R.; Dongiovanni, P.; Rychlicki, C.; Ferri, N.; Camma', C.; Fracanzani, A.; Pierantonelli, I.; DI MARCO, V.; Meroni, M.; Giordano, D.; Grimaudo, S.; Maggioni, M.; Cabibi, D.; Fargion, S.; Craxi, A.
  • Anno di pubblicazione: 2017
  • Tipologia: Articolo in rivista (Articolo in rivista)
  • OA Link: http://hdl.handle.net/10447/228559

Abstract

Contrasting data have been reported on the role of irisin, a novel myokine encoded by the FNDC5 gene, in NAFLD pathogenesis. We tested in patients with suspected NASH the association of FNDC5 variants, hepatic expression and circulating irisin with liver damage(F2-F4 fibrosis as main outcome). We also investigated whether irisin modulates hepatocellular fat accumulation and stellate cell activation in experimental models.